These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 27983916)
1. Silencing of A-Kinase Anchor Protein 4 (AKAP4) Inhibits Proliferation and Progression of Thyroid Cancer. Han J; Gao W; Su D; Liu Y Oncol Res; 2017 Jul; 25(6):873-878. PubMed ID: 27983916 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of A-kinase anchor protein 4 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in human gastric cancer cells. Li Q; Tang H; Hu F; Qin C J Cell Biochem; 2018 Dec; 119(12):10013-10020. PubMed ID: 30145836 [TBL] [Abstract][Full Text] [Related]
3. A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer. Jagadish N; Parashar D; Gupta N; Agarwal S; Purohit S; Kumar V; Sharma A; Fatima R; Topno AP; Shaha C; Suri A J Exp Clin Cancer Res; 2015 Nov; 34():142. PubMed ID: 26590805 [TBL] [Abstract][Full Text] [Related]
4. Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo. Saini S; Agarwal S; Sinha A; Verma A; Parashar D; Gupta N; Ansari AS; Lohiya NK; Jagadish N; Suri A Cancer Gene Ther; 2013 Jul; 20(7):413-20. PubMed ID: 23764900 [TBL] [Abstract][Full Text] [Related]
5. Silencing of A-kinase anchor protein 4 inhibits the metastasis and growth of non-small cell lung cancer. Zhang B; Hu Q; Zhang J; Jin Z; Ruan Y; Xia L; Wang C Bioengineered; 2022 Mar; 13(3):6895-6907. PubMed ID: 35253625 [TBL] [Abstract][Full Text] [Related]
6. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of PFTAIRE Protein Kinase 1 (PFTK1) Inhibits Proliferation, Invasion, and EMT in Colon Cancer Cells. Zhu J; Liu C; Liu F; Wang Y; Zhu M Oncol Res; 2016; 24(3):137-44. PubMed ID: 27458094 [TBL] [Abstract][Full Text] [Related]
8. Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Xu X; Ding H; Rao G; Arora S; Saclarides CP; Esparaz J; Gattuso P; Solorzano CC; Prinz RA Endocr Relat Cancer; 2012 Apr; 19(2):167-79. PubMed ID: 22241722 [TBL] [Abstract][Full Text] [Related]
9. LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway. Sui X; Sui Y; Wang Y Mol Med Rep; 2018 Jun; 17(6):7521-7528. PubMed ID: 29620212 [TBL] [Abstract][Full Text] [Related]
10. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition. Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662 [TBL] [Abstract][Full Text] [Related]
11. Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression. You MH; Jeon MJ; Kim SR; Lee WK; Cheng SY; Jang G; Kim TY; Kim WB; Shong YK; Kim WG Sci Rep; 2021 Jan; 11(1):2054. PubMed ID: 33479369 [TBL] [Abstract][Full Text] [Related]
12. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway. Wang SC; Chai DS; Chen CB; Wang ZY; Wang L Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. Ramírez-Moya J; Wert-Lamas L; Santisteban P Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884 [TBL] [Abstract][Full Text] [Related]
14. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway. Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171 [TBL] [Abstract][Full Text] [Related]
15. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion. Gao W; Han J Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of SOX9 Inhibits the Proliferation, Invasion, and EMT in Thyroid Cancer Cells. Huang J; Guo L Oncol Res; 2017 Jan; 25(2):167-176. PubMed ID: 28277188 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo. Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755 [TBL] [Abstract][Full Text] [Related]
18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway. Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510 [TBL] [Abstract][Full Text] [Related]
19. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells. Jeon MJ; Kim WG; Lim S; Choi HJ; Sim S; Kim TY; Shong YK; Kim WB Mol Cell Endocrinol; 2016 Jan; 419():113-23. PubMed ID: 26463583 [TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway. Han B; Cui H; Kang L; Zhang X; Jin Z; Lu L; Fan Z Tumour Biol; 2015 Aug; 36(8):6295-304. PubMed ID: 25854169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]